Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate

Peter L. Choyke, Howard A. Austin, Joseph A. Frank, Mary E. Girton, Richard L. Diggs, Andrew J. Dwyer, Laurieta Miller, Robert Nussenblatt, Henry Mcfarland, Theodore Simon

Research output: Contribution to journalArticle

Abstract

Technetium (99mTc)-diethylene triamine pentaacetic acid (DTPA) hydrated clearance studies are accurate for determining GFR but require special facilities for handling and measuring samples. We investigated the potential of a non-radioactive paramagnetic analog, Gadolinium (Gd)-diethylene triamine pentaacetic acid (DTPA), an approved NMR contrast agent, as a glomerular filtration marker. Instead of relying on the radioactivity of technetium, this test is based on the fact that gadolinium induces alterations in the NMR T1 relaxation times in blood and urine samples. Ninety patients underwent simultaneous determinations of GFR using 1 mCi of Tc-DTPA and 0.05 mmol/kg Gd-DTPA (Berlex Labs) IV. The patients were hydrated with oral and intravenous fluid. Following a one hour equilibrium period, three or four consecutive urine collections were obtained; plasma samples were acquired at the beginning and end of each approximately 20-minute interval. 99mTc-DTPA radioactivity was determined with a scintillation counter. T1 relaxation times were measured on a 10 MHz NMR spectrometer. These were converted to Gd-DTPA concentration by comparison with standard solutions. The Gd-DTPA derived GFR closely approximated the 99mTc-DTPA derived GFR which ranged from 15 to 147 ml/min. The equation and correlation coefficient of the regression line is y = 1.04 × -2.2, r = 0.94. Thus, Gd-DTPA is a safe, non-radioactive indicator of GFR that may provide an alternative renal clearance method for clinical studies of progressive renal disease and nephrotoxicity.

Original languageEnglish (US)
Pages (from-to)1595-1598
Number of pages4
JournalKidney International
Volume41
Issue number6
StatePublished - Jun 1992
Externally publishedYes

Fingerprint

Gadolinium
Glomerular Filtration Rate
Acids
Technetium
Radioactivity
Kidney
diethylenetriamine
Scintillation Counting
Urine Specimen Collection
Contrast Media
Urine

ASJC Scopus subject areas

  • Nephrology

Cite this

Choyke, P. L., Austin, H. A., Frank, J. A., Girton, M. E., Diggs, R. L., Dwyer, A. J., ... Simon, T. (1992). Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney International, 41(6), 1595-1598.

Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. / Choyke, Peter L.; Austin, Howard A.; Frank, Joseph A.; Girton, Mary E.; Diggs, Richard L.; Dwyer, Andrew J.; Miller, Laurieta; Nussenblatt, Robert; Mcfarland, Henry; Simon, Theodore.

In: Kidney International, Vol. 41, No. 6, 06.1992, p. 1595-1598.

Research output: Contribution to journalArticle

Choyke, PL, Austin, HA, Frank, JA, Girton, ME, Diggs, RL, Dwyer, AJ, Miller, L, Nussenblatt, R, Mcfarland, H & Simon, T 1992, 'Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate', Kidney International, vol. 41, no. 6, pp. 1595-1598.
Choyke PL, Austin HA, Frank JA, Girton ME, Diggs RL, Dwyer AJ et al. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney International. 1992 Jun;41(6):1595-1598.
Choyke, Peter L. ; Austin, Howard A. ; Frank, Joseph A. ; Girton, Mary E. ; Diggs, Richard L. ; Dwyer, Andrew J. ; Miller, Laurieta ; Nussenblatt, Robert ; Mcfarland, Henry ; Simon, Theodore. / Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. In: Kidney International. 1992 ; Vol. 41, No. 6. pp. 1595-1598.
@article{df6f2a040fc04e268f2c39c8ce429d47,
title = "Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate",
abstract = "Technetium (99mTc)-diethylene triamine pentaacetic acid (DTPA) hydrated clearance studies are accurate for determining GFR but require special facilities for handling and measuring samples. We investigated the potential of a non-radioactive paramagnetic analog, Gadolinium (Gd)-diethylene triamine pentaacetic acid (DTPA), an approved NMR contrast agent, as a glomerular filtration marker. Instead of relying on the radioactivity of technetium, this test is based on the fact that gadolinium induces alterations in the NMR T1 relaxation times in blood and urine samples. Ninety patients underwent simultaneous determinations of GFR using 1 mCi of Tc-DTPA and 0.05 mmol/kg Gd-DTPA (Berlex Labs) IV. The patients were hydrated with oral and intravenous fluid. Following a one hour equilibrium period, three or four consecutive urine collections were obtained; plasma samples were acquired at the beginning and end of each approximately 20-minute interval. 99mTc-DTPA radioactivity was determined with a scintillation counter. T1 relaxation times were measured on a 10 MHz NMR spectrometer. These were converted to Gd-DTPA concentration by comparison with standard solutions. The Gd-DTPA derived GFR closely approximated the 99mTc-DTPA derived GFR which ranged from 15 to 147 ml/min. The equation and correlation coefficient of the regression line is y = 1.04 × -2.2, r = 0.94. Thus, Gd-DTPA is a safe, non-radioactive indicator of GFR that may provide an alternative renal clearance method for clinical studies of progressive renal disease and nephrotoxicity.",
author = "Choyke, {Peter L.} and Austin, {Howard A.} and Frank, {Joseph A.} and Girton, {Mary E.} and Diggs, {Richard L.} and Dwyer, {Andrew J.} and Laurieta Miller and Robert Nussenblatt and Henry Mcfarland and Theodore Simon",
year = "1992",
month = "6",
language = "English (US)",
volume = "41",
pages = "1595--1598",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate

AU - Choyke, Peter L.

AU - Austin, Howard A.

AU - Frank, Joseph A.

AU - Girton, Mary E.

AU - Diggs, Richard L.

AU - Dwyer, Andrew J.

AU - Miller, Laurieta

AU - Nussenblatt, Robert

AU - Mcfarland, Henry

AU - Simon, Theodore

PY - 1992/6

Y1 - 1992/6

N2 - Technetium (99mTc)-diethylene triamine pentaacetic acid (DTPA) hydrated clearance studies are accurate for determining GFR but require special facilities for handling and measuring samples. We investigated the potential of a non-radioactive paramagnetic analog, Gadolinium (Gd)-diethylene triamine pentaacetic acid (DTPA), an approved NMR contrast agent, as a glomerular filtration marker. Instead of relying on the radioactivity of technetium, this test is based on the fact that gadolinium induces alterations in the NMR T1 relaxation times in blood and urine samples. Ninety patients underwent simultaneous determinations of GFR using 1 mCi of Tc-DTPA and 0.05 mmol/kg Gd-DTPA (Berlex Labs) IV. The patients were hydrated with oral and intravenous fluid. Following a one hour equilibrium period, three or four consecutive urine collections were obtained; plasma samples were acquired at the beginning and end of each approximately 20-minute interval. 99mTc-DTPA radioactivity was determined with a scintillation counter. T1 relaxation times were measured on a 10 MHz NMR spectrometer. These were converted to Gd-DTPA concentration by comparison with standard solutions. The Gd-DTPA derived GFR closely approximated the 99mTc-DTPA derived GFR which ranged from 15 to 147 ml/min. The equation and correlation coefficient of the regression line is y = 1.04 × -2.2, r = 0.94. Thus, Gd-DTPA is a safe, non-radioactive indicator of GFR that may provide an alternative renal clearance method for clinical studies of progressive renal disease and nephrotoxicity.

AB - Technetium (99mTc)-diethylene triamine pentaacetic acid (DTPA) hydrated clearance studies are accurate for determining GFR but require special facilities for handling and measuring samples. We investigated the potential of a non-radioactive paramagnetic analog, Gadolinium (Gd)-diethylene triamine pentaacetic acid (DTPA), an approved NMR contrast agent, as a glomerular filtration marker. Instead of relying on the radioactivity of technetium, this test is based on the fact that gadolinium induces alterations in the NMR T1 relaxation times in blood and urine samples. Ninety patients underwent simultaneous determinations of GFR using 1 mCi of Tc-DTPA and 0.05 mmol/kg Gd-DTPA (Berlex Labs) IV. The patients were hydrated with oral and intravenous fluid. Following a one hour equilibrium period, three or four consecutive urine collections were obtained; plasma samples were acquired at the beginning and end of each approximately 20-minute interval. 99mTc-DTPA radioactivity was determined with a scintillation counter. T1 relaxation times were measured on a 10 MHz NMR spectrometer. These were converted to Gd-DTPA concentration by comparison with standard solutions. The Gd-DTPA derived GFR closely approximated the 99mTc-DTPA derived GFR which ranged from 15 to 147 ml/min. The equation and correlation coefficient of the regression line is y = 1.04 × -2.2, r = 0.94. Thus, Gd-DTPA is a safe, non-radioactive indicator of GFR that may provide an alternative renal clearance method for clinical studies of progressive renal disease and nephrotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026773524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026773524&partnerID=8YFLogxK

M3 - Article

C2 - 1501414

AN - SCOPUS:0026773524

VL - 41

SP - 1595

EP - 1598

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -